Jiangxi Sanxin Medtec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 19, 2022 at 08:45 am
Share
Jiangxi Sanxin Medtec Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 321.5 million compared to CNY 246.15 million a year ago. Revenue was CNY 321.5 million compared to CNY 246.15 million a year ago. Net income was CNY 47.45 million compared to CNY 34.04 million a year ago. Basic earnings per share from continuing operations was CNY 0.1204 compared to CNY 0.0864 a year ago. Diluted earnings per share from continuing operations was CNY 0.1204 compared to CNY 0.0864 a year ago.
Jiangxi Sanxin Medtec Co Ltd is a China-based company mainly engaged in the research and development, manufacturing, sales and service of medical devices. The Company's main products include blood purification, infusion, cardiothoracic surgery and diabetes treatment devices, early and mid-stage kidney disease intervention and treatment devices, and vascular intervention devices. The Company's core business is blood purification products, which are used in blood purification treatment for end-stage renal disease (uremia), acute and chronic renal failure, and drug or other substance poisoning. The Company mainly conducts its business in the domestic and foreign markets.
JIANGXI SANXIN MEDTEC CO.,LTD. 
